课题基金 / 基金详情

Exploratory research for effective application of molecular targeted drugs by analysis of regulatory T cell variation in oral cancer treatment

Exploratory research for effective application of molecular targeted drugs by analysis of regulatory T cell variation in oral cancer treatment
通过分析调节性T细胞变异在口腔癌治疗中有效应用分子靶向药物的探索性研究
批准号:
19K18968
负责人:
Fukumoto Chonji
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Early-Career Scientists
财政年份:
2019
资助国家:
日本
项目状态:
已结题
起止时间:
2019-04-01 至 2022-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Bone marrow-derived cells conribute to develop squamous cell carcinoma
骨髓来源的细胞有助于发展鳞状细胞癌
DOI: --
发表时间: 2019
期刊:
影响因子: --
作者: [Yuta Sawatani, Yusuke Komiyama, Ryouta Kamimura, Michiko Shimura, Tomonori Hasegawa, Chonji Fukumoto, Atsushi Fujita, Takahiro Wakui, Hitoshi Kawamata]
通讯作者: Hitoshi Kawamata
DOI: 10.1186/s12877-020-01902-3
发表时间: 2020-11-20
期刊: BMC geriatrics
影响因子: 4.1
作者: [Fukumoto C, Ogisawa S, Tani M, Hyodo T, Kamimura R, Sawatani Y, Hasegawa T, Komiyama Y, Fujita A, Wakui T, Haruyama Y, Kobashi G, Kawamata H]
通讯作者: Kawamata H
A retrospective cohort study: Effectiveness of preemptive postsurgical therapy by cetuximab for oral squamous cell carcinoma patients with major risk
一项回顾性队列研究:西妥昔单抗抢先术后治疗对高危口腔鳞状细胞癌患者的有效性
DOI: --
发表时间: 2021
期刊:
影响因子: --
作者: [Chonji Fukumoto, Toshiki Hyodo, Ryo Oshima, Yuta Sawatani, Ryo Shiraishi, Ryouta Kamimura, Sayaka Izumi, Takahiro Wakui, Atsushi Fujita, Hitoshi Kawamata]
通讯作者: Hitoshi Kawamata
Paclitaxel potentiated the anticancer effect of cetuximab via enhancing the antibody-dependent cellular cytotoxicity on oral squamous cell carcinoma cells in vitro.
紫杉醇通过增强体外对口腔鳞状细胞癌细胞的抗体依赖性细胞毒性来增强西妥昔单抗的抗癌作用。
DOI: --
发表时间: 2020
期刊:
影响因子: --
作者: [Sawatani Yuta, Komiyama Yuske, Kamimura Ryouta, Shimura Michiko, Hasegawa Tomonori, Fukumoto Chonji, Kuribayashi Nobuyuki, Fujita Atsushi, Wakui Takahiro, Nakashiro Koh-ichi, Uchida Daisuke, Kawamata Hitoshi]
通讯作者: Kawamata Hitoshi
8
    海外基金